Announcements Trials
Browse Landscape

Status

Unknown 4Completed 3

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 13Observational 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Prostatic Neoplasms 1214Urinary Bladder Neoplasms 386Carcinoma, Renal Cell 329Kidney Neoplasms 205Neoplasms 157Breast Neoplasms 146Lung Neoplasms 101Carcinoma, Transitional Cell 99Colorectal Neoplasms 77Testicular Neoplasms 74Ovarian Neoplasms 62Melanoma 60Pancreatic Neoplasms 57Colonic Neoplasms 50Carcinoma, Non-Small-Cell Lung 50Head and Neck Neoplasms 47Stomach Neoplasms 45Non-Muscle Invasive Bladder Neoplasms 45Disease 45Neoplasm Metastasis 41Liver Neoplasms 40Uterine Cervical Neoplasms 39Esophageal Neoplasms 37Wilms Tumor 36Prostatic Hyperplasia 36Adenocarcinoma 33Multiple Myeloma 32Urologic Neoplasms 30Sarcoma 30Recurrence 30

Interventions

radium Ra 223 dichloride 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Gonadotropin-Releasing Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Observational × Advanced Prostate Cancer × Genitourinary × Clear all
NCT02362620 2020-01-27

PROSTAC

Centro Nacional de Investigaciones Oncologicas CARLOS III

Unknown
402 enrolled
Genitourinary

Advanced Prostate Cancer

NCT02787837 2020-01-27

PROSABI

Centro Nacional de Investigaciones Oncologicas CARLOS III

Unknown
220 enrolled
Genitourinary

Advanced Prostate Cancer

NCT02922218 2020-01-27

PROSENZA

Centro Nacional de Investigaciones Oncologicas CARLOS III

Unknown
187 enrolled
Genitourinary

Advanced Prostate Cancer

NCT02925702 2020-01-27

PRORADIUM

Centro Nacional de Investigaciones Oncologicas CARLOS III

Unknown
161 enrolled
Genitourinary

Advanced Prostate Cancer

NCT02234089 2019-07-05

ProComD

Ferring Pharmaceuticals

Completed
461 enrolled
Genitourinary

Advanced Prostate Cancer

NCT01383863 2019-01-14

TRIPTOCARE LT

Ipsen

Completed
180 enrolled
Genitourinary

Advanced Prostate Cancer

NCT00871585 2010-04-15

Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide

AstraZeneca

Completed
340 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡